Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $3.08 billion. The enterprise value is $2.47 billion.
Important Dates
The next estimated earnings date is Thursday, October 31, 2024, before market open.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 63.76 million shares outstanding. The number of shares has increased by 13.96% in one year.
| Shares Outstanding | 63.76M |
| Shares Change (YoY) | +13.96% |
| Shares Change (QoQ) | +3.23% |
| Owned by Insiders (%) | 1.31% |
| Owned by Institutions (%) | 74.88% |
| Float | 42.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 35.61 |
| Forward PS | 56.75 |
| PB Ratio | 4.35 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 27.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.45, with a Debt / Equity ratio of 0.13.
| Current Ratio | 8.45 |
| Quick Ratio | 8.23 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -950.80 |
Financial Efficiency
Return on equity (ROE) is -28.18% and return on invested capital (ROIC) is -17.59%.
| Return on Equity (ROE) | -28.18% |
| Return on Assets (ROA) | -16.04% |
| Return on Capital (ROIC) | -17.59% |
| Revenue Per Employee | $473,529 |
| Profits Per Employee | -$844,139 |
| Employee Count | 187 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +298.11% in the last 52 weeks. The beta is 2.22, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 2.22 |
| 52-Week Price Change | +298.11% |
| 50-Day Moving Average | 46.54 |
| 200-Day Moving Average | 39.05 |
| Relative Strength Index (RSI) | 56.57 |
| Average Volume (20 Days) | 360,315 |
Short Selling Information
The latest short interest is 8.81 million, so 13.81% of the outstanding shares have been sold short.
| Short Interest | 8.81M |
| Short Previous Month | 9.49M |
| Short % of Shares Out | 13.81% |
| Short % of Float | 20.49% |
| Short Ratio (days to cover) | 19.78 |
Income Statement
In the last 12 months, KYMR had revenue of $88.55 million and -$157.85 million in losses. Loss per share was -$2.42.
| Revenue | 88.55M |
| Gross Profit | -120.56M |
| Operating Income | -180.65M |
| Pretax Income | -157.85M |
| Net Income | -157.85M |
| EBITDA | -176.97M |
| EBIT | -180.65M |
| Loss Per Share | -$2.42 |
Full Income StatementBalance Sheet
The company has $509.95 million in cash and $88.18 million in debt, giving a net cash position of $614.22 million or $9.63 per share.
| Cash & Cash Equivalents | 509.95M |
| Total Debt | 88.18M |
| Net Cash | 614.22M |
| Net Cash Per Share | $9.63 |
| Equity (Book Value) | 684.92M |
| Book Value Per Share | 11.12 |
| Working Capital | 463.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$106.13 million and capital expenditures -$31.79 million, giving a free cash flow of -$137.92 million.
| Operating Cash Flow | -106.13M |
| Capital Expenditures | -31.79M |
| Free Cash Flow | -137.92M |
| FCF Per Share | -$2.16 |
Full Cash Flow StatementMargins
Gross margin is -136.15%, with operating and profit margins of -204.01% and -178.27%.
| Gross Margin | -136.15% |
| Operating Margin | -204.01% |
| Pretax Margin | -178.27% |
| Profit Margin | -178.27% |
| EBITDA Margin | -199.85% |
| EBIT Margin | -204.01% |
| FCF Margin | -155.76% |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.96% |
| Shareholder Yield | -13.96% |
| Earnings Yield | -5.12% |
| FCF Yield | -4.47% |
Dividend DetailsAnalyst Forecast
The average price target for KYMR is $49.00, which is 1.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $49.00 |
| Price Target Difference | 1.30% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 22.85% |
| EPS Growth Forecast (5Y) | -4.53% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 5.76 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.76 |
| Piotroski F-Score | 4 |